Pharmaceutical GMP Readiness in Switzerland
Switzerland regulates medicines through Swissmedic under the Therapeutic Products Act (TPA / HMG SR 812.21) and the Medicinal Products Licensing Ordinance (AMBV/OAMéd).
In Short
- Swissmedic is the federal authority for therapeutic products.
- Every manufacturing and import authorisation requires a named FvP (the Swiss QP) accountable for GMP and batch release.
- Under the EU–CH MRA for human medicines, GMP certificates and inspection outcomes are mutually recognized — EU batch testing waivers apply, and Swissmedic…
Swiss GMP follows PIC/S; the EU–Switzerland Mutual Recognition Agreement (MRA) means EU and Swiss GMP inspections recognize each other for human medicines. Batch release uses a Swiss Qualified Person (Fachtechnisch verantwortliche Person, FvP). This guide covers the Switzerland-specific layer over an ICH Q10 PQS.
Regulator and Legal Basis
Swissmedic is the federal authority for therapeutic products. TPA is the statutory base; AMBV/OAMéd governs manufacturing, import, wholesale, and brokering licences (BTM, GDP).
More on regulator and Legal Basis
Swissmedic is a PIC/S member and references EudraLex Volume 4 plus Swiss annexes. Cantonal authorities cooperate on wholesale and pharmacy oversight.
FvP / Qualified Person and licence model
Every manufacturing and import authorisation requires a named FvP (the Swiss QP) accountable for GMP and batch release. The FvP function is statutory and personally liable.
More on fvP / Qualified Person and licence model
A single FvP can cover one or more sites with adequate presence and competence.
EU MRA, GDP, and Serialization
Under the EU–CH MRA for human medicines, GMP certificates and inspection outcomes are mutually recognized — EU batch testing waivers apply, and Swissmedic inspections cover EU MRA partners' needs and vice versa. Swiss GDP mirrors EU GDP.
More on eU MRA, GDP, and Serialization
Switzerland is NOT in the EU FMD scheme — packs for the Swiss market do not require EMVS verification, but most manufacturers retain the 2D Datamatrix for global packs.
Inspection Style and Common Findings
Swissmedic inspections are PIC/S-style with critical/major/other classifications and a published certificate. Common findings: Annex 1 contamination control, computerised systems / Annex 11, data integrity (ALCOA+), and supplier oversight.
More on inspection Style and Common Findings
Swissmedic is small but technically demanding; expect detailed scientific debate at inspection.
A 90–180 day Switzerland readiness path
- Days 0–30
confirm BTM/GDP licence scope, appoint FvP(s), and document the EU MRA reliance position for imported batches.
- Days 31–90
close Annex 1 and Annex 11 gaps; align data integrity to MHRA/PIC/S PI 041.
- Days 91–180
mock inspection against EudraLex Vol 4 + Swiss annexes; request Swissmedic inspection.
Questions
Does the EU–CH MRA cover all medicines?
It covers human medicinal products (chemicals and biologicals); coverage of veterinary medicines, IMPs, and some advanced therapies is narrower. Always check the current MRA annex before relying on it for a specific product class.
Is FvP the same as an EU QP?
Functionally equivalent — the FvP carries personal accountability for GMP compliance and batch release. Eligibility is set by Swiss law and is generally accepted by EU QPs under the MRA, though formal cross-recognition of the role itself is not automatic.
Do we need FMD serialization for Swiss packs?
Not legally. Switzerland is outside the EU FMD/EMVS system. Many manufacturers keep the 2D Datamatrix carrier for traceability and to share packs with EU markets via parallel trade rules, but Swissmedic does not enforce FMD.
Practical orientation, not legal advice. Rules differ by jurisdiction; your quality and compliance team decides what applies.
The Pharmaceutical Operations Guide
Right material. Right record. Released by a person.
- Who decides, and who may not
- Supplier to finished bulk
- Test, review, investigate
- Packs, serialisation and recall
Plus Evidence map and four worksheets.
Get the pharmaceutical guideWe ask for your name and email so we can handle this request. The full guide then opens on this site, ready to translate, print or save. Privacy policy. Practical orientation, not legal advice; your quality unit decides which rules apply.
UltimateFree guide
The Pharmaceutical Operations Guide
Right material. Right record. Released by a person.
Keep reading
Global Pharmaceutical GMP Readiness: Principles That Travel- Australia Pharmaceutical GMP Readiness: TGA and PIC/S GMP
Brazil Pharmaceutical GMP Readiness: ANVISA RDC 658/2022
Canada Drug GMP Readiness: Food and Drug Regulations Part C, Division 2
China Pharmaceutical GMP Readiness: NMPA and China GMP
EU GMP Guide: EudraLex Volume 4 Chapters, Annexes and Who Decides